Global Female Contraceptive Market Growth 2025-2031

The global Female Contraceptive market size is predicted to grow from US$ 19410 million in 2025 to US$ 22810 million in 2031; it is expected to grow at a CAGR of 2.7% from 2025 to 2031.

The impact of the latest U.S. tariff measures and the corresponding policy responses from countries worldwide on market competitiveness, regional economic performance, and supply chain configurations will be comprehensively evaluated in this report.

Female contraceptives, also known as female birth control are methods of preventing pregnancy that primarily involve the female physiology.

Female contraceptive devices account for major shares of the contraceptive pills market throughout the forecast period. The increasing adoption of female contraceptive devices will drive the growth of this product segment in the female contraceptive market.

LP Information, Inc. (LPI) ' newest research report, the “Female Contraceptive Industry Forecast” looks at past sales and reviews total world Female Contraceptive sales in 2024, providing a comprehensive analysis by region and market sector of projected Female Contraceptive sales for 2025 through 2031. With Female Contraceptive sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Female Contraceptive industry.

This Insight Report provides a comprehensive analysis of the global Female Contraceptive landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Female Contraceptive portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Female Contraceptive market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Female Contraceptive and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Female Contraceptive.

This report presents a comprehensive overview, market shares, and growth opportunities of Female Contraceptive market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:
Female Contraceptive Devices
Female Contraceptive Drugs

Segmentation by Application:
Online Stores
Retail Outlets

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Merck
Pfizer
Allergan
Bayer
Okamoto Industries
Reckitt Benckiser
Lupin Pharmaceuticals
Foundation Consumer Healthcare
Teva Pharmaceuticals
Ansell
Ferring Pharmaceuticals
Fuji Latex
Janssen Pharmaceuticals

Key Questions Addressed in this Report

What is the 10-year outlook for the global Female Contraceptive market?

What factors are driving Female Contraceptive market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Female Contraceptive market opportunities vary by end market size?

How does Female Contraceptive break out by Type, by Application?

Please note: The report will take approximately 2 business days to prepare and deliver. Show more